4D Molecular Therapeutics, Inc. Quarterly Current Ratio in % from Q3 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
4D Molecular Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q3 2021 to Q3 2024.
  • 4D Molecular Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 2.25K %, a 23.5% increase year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 2.25K +429 +23.5% Sep 30, 2024
Q2 2024 2.35K +549 +30.5% Jun 30, 2024
Q1 2024 2.2K +546 +33.1% Mar 31, 2024
Q4 2023 1.85K +158 +9.36% Dec 31, 2023
Q3 2023 1.82K +85.1 +4.9% Sep 30, 2023
Q2 2023 1.8K +116 +6.89% Jun 30, 2023
Q1 2023 1.65K -189 -10.2% Mar 31, 2023
Q4 2022 1.69K -124 -6.85% Dec 31, 2022
Q3 2022 1.74K -116 -6.25% Sep 30, 2022
Q2 2022 1.68K Jun 30, 2022
Q1 2022 1.84K Mar 31, 2022
Q4 2021 1.82K Dec 31, 2021
Q3 2021 1.85K Sep 30, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.